Cosette Pharmaceuticals Acquires Mayne Pharma
Cosette Pharmaceuticals, Inc. is acquiring Mayne Pharma. Cosette will acquire all the outstanding shares of Mayne Pharma Group Limited at AUD$7.40/share for a total consideration of approximately USD $430 Million. The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recommended that its shareholders vote in […]